Insulin Receptor phospho Y1361 Antibody from ROCKLAND IMMUNOCHEMICALS INC.

Search, find, compare suppliers for anti-Insulin Receptor phospho Y1361 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityInsulin Receptor phospho Y1361
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatserum
Size25 µL
Concentration1.0 mg/ml
ApplicationsELISA, Immunohistochemistry, IF Microscopy, Western Blot
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis affinity purified antibody is directed against human Insulin Receptor. Rabbit Anti-Insulin Receptor pY1361 Antibody was prepared from monospecific antiserum by delipidation and defibrination, affinity purification, followed by cross adsorption. This phospho specific polyclonal antibody is specific for pY1361 human Insulin Receptor. Reactivity with non-phosphorylated Y1361 is minimal. A BLAST analysis was used to suggest cross-reactivity with the antigen based on 100% homology with the immunizing sequence to human, rat, mouse, and xenopus laevis. Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Anti-Insulin Receptor pY1361 Antibody is useful for researchers interested in Donohue Syndrome, Insulin-Resistant Diabetes Mellitus, RET signaling, AMP-activated Protein Kinase (AMPK) Signaling Pathways, and protein tyrosine kinase activity.
ImmunogenAnti-Insulin Receptor pY1361 antibody was prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to the C-Terminal portion near the phosphorylation Y1361 of the human Insulin Receptor conjugated to Keyhole Limpet Hemocyanin (KLH).
Other NamesInsulin Receptor, EC 2.7.10.1, IR, CD220 Antigen, HHF5, Rabbit anti-Insulin receptor, INSR
Gene, Accession #INSR, Gene ID: 3643, NCBI: NP_000199.2, UniProt: P06213
Catalog #600-401-MR0S
Price$125
Order / More InfoInsulin Receptor phospho Y1361 Antibody from ROCKLAND IMMUNOCHEMICALS INC.
Product Specific Referencesn/a
ROCKLAND IMMUNOCHEMICALS INC.
ROCKLAND IMMUNOCHEMICALS INC.
ROCKLAND IMMUNOCHEMICALS INC.
PO Box 5199
Limerick PA 19468
P: 484-791-3823
P: 800.656.7625
F: 484.369.8654

orders@rockland.com
Technical Support: tech@rockland.com

https://www.rockland.com/

Profile of ROCKLAND IMMUNOCHEMICALS INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.